CN Stock MarketDetailed Quotes

301277 Newland Pharmaceutical

Watchlist
  • 11.45
  • -0.36-3.05%
Market Closed Apr 30 15:00 CST
4.49BMarket Cap25.73P/E (TTM)

About Newland Pharmaceutical Company

The company was founded in 2005. It is a manufacturer of L-hydroxyphenylglycine, an important global amoxicillin synthesis side chain. It has led or participated in formulating industry standards for various products such as L-hydroxyphenylglycine, p-toluene sulfonic acid, and L-hydroxyphenylglycine methyl ester. It is the second batch of specialized and innovative enterprises in Henan Province. The company is mainly engaged in the production, development and sale of pharmaceutical intermediates, APIs and chemical preparations. The company's main products are L-p-hydroxyphenylglycine series products and p-toluene sulfonate products. The company won the honors of “Waste-free Factory” in Xuchang City and “Waste-free Enterprise” by the Henan Green Development Association.

Company Profile

Short Name-A新天地
Symbol-A301277
Company NameNewland Pharmaceutical Co., Ltd.
Listing DateNov 16, 2022
Issue Price27.00
Shares Offered33.36M share(s)
FoundedSep 15, 2005
Legal Representativejianzhong xie
General Managerluwei zhang
Secretaryyushan xie
Accounting FirmGrant Thornton Certified Public Accountants (Special General Partnership)
Securities Representativeyushan xie
Legal CounselBeijing Tianyuan Law Firm
Employees1004
Phone0374-6103777
Office AddressEast side of the southern section of Weiwu Road, Changge City
Zip Code461500
Registered AddressEast side of the southern section of Weiwu Road, Changge City, Xuchang City, Henan Province
Fax0374-6105968
Emailboard@hnnewland.com
Business License411082100006960
BusinessProduction, development, and sale of pharmaceutical intermediates, APIs, and chemical preparations (excluding hazardous chemicals, with the exception of products prohibited by the country); import and export of goods or technology (excluding imports and exports of goods and technology prohibited by the country or involving administrative examination and approval).

Company Executives

  • Name
  • Position
  • Salary
  • jianzhong xie
  • Chairman, Directors, Nomination Committee Members, Chairman of the Strategy Committee, Member of the Remuneration and Assessment Committee, Audit Committee Member
  • 585.40K
  • wanmin liu
  • Vice Chairman, Directors
  • 452.30K
  • hongmin liu
  • Directors
  • 600.10K
  • chao liu
  • Directors, Deputy General Manager, Chief Engineer
  • 412.50K
  • binggang zhang
  • Directors
  • --
  • luwei zhang
  • Directors, General Manager, Strategy Committee Member
  • 488.00K
  • yu ke
  • Independent Directors, Chairman of the Nomination Committee, Strategy Committee Member, Member of the Remuneration and Assessment Committee
  • 60.00K
  • jingbao wang
  • Independent Directors, Audit Committee Member, Nomination Committee Members
  • 60.00K
  • faliang jia
  • Independent Directors, Chairman of the Audit Committee, Chairman of the Remuneration and Assessment Committee
  • 60.00K
  • yushan xie
  • Board Secretary, Securities Affairs Representative
  • --
  • heping xu
  • Chairman of the Supervisory Board, Auditors
  • --
  • zhangchun liu
  • Auditors
  • --
  • liying wang
  • Deputy General Manager
  • 321.10K
  • qingkui wang
  • Chief Financial Officer
  • 400.50K
  • weidong wu
  • Employee Supervisors
  • 125.30K

Market Insights

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More